Peers for comparison


Market capitalization
‪473.53 B‬ EURMega cap
‪3.56 B‬ EUR
‪52.07 B‬ EUR
Beta (1Y)
0.01
Next report date
Report period
EPS estimate
Revenue estimate
Employees (FY)
‪57 K‬
Change (1Y)
‪+2 K‬+3.64%
Revenue / Employee (1Y)
‪913.56 K‬ EUR
Net income / Employee (1Y)
‪62.53 K‬ EUR

Company info


CEO
Robert A. Michael
Website
Headquarters
North Chicago
Founded
2011
IPO date
Jan 2, 2013
ISIN
US00287Y1091
CUSIP
00287Y109
FIGI
BBG003Q17NP7
Identifiers
ISIN US00287Y1091
CFI code
ESVUFR
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders such as Parkinson’s disease, metabolic disorders, including thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.
Performance
Revenue to profit conversion
Debt level and coverage
EPS
Next:—
Summarizing what the indicators are suggesting.
Neutral
Neutral
Neutral
An aggregate view of professional's ratings.
Neutral
Neutral
Neutral
Displays a symbol's price movements over previous years to identify recurring trends.
Maturity dateMar 15, 2035
Coupon4.55% (Fixed)
Maturity dateSep 15, 2066
Coupon6.10% (Fixed)
Maturity dateMar 15, 2064
Coupon5.50% (Fixed)
Maturity dateMar 15, 2066
Coupon5.65% (Fixed)
Maturity dateMay 14, 2046
Coupon4.45% (Fixed)
Maturity dateNov 21, 2049
Coupon4.25% (Fixed)
Maturity dateMar 15, 2056
Coupon5.55% (Fixed)
Maturity dateMar 15, 2054
Coupon5.40% (Fixed)
Maturity dateMay 14, 2045
Coupon4.70% (Fixed)
Maturity dateSep 15, 2056
Coupon6.00% (Fixed)

See all 4AB bonds 

Weight0.80%
Market value‪13.85 B‬
Weight0.72%
Market value‪13.06 B‬
Weight0.81%
Market value‪6.99 B‬
Weight0.81%
Market value‪6.39 B‬
Weight1.88%
Market value‪5.01 B‬
Weight7.65%
Market value‪3.85 B‬
Weight2.18%
Market value‪2.95 B‬
Weight2.11%
Market value‪2.13 B‬
Weight6.73%
Market value‪1.60 B‬
Weight0.81%
Market value‪1.48 B‬
Weight3.04%
Market value‪1.39 B‬

Explore more ETFs 

Frequently asked questions


AbbVie, Inc. is scheduled to release its next earnings report on Feb 3, 2027.

Why it matters:
– Key event: Earnings often drive significant price moves
– Market expectations: Traders watch revenue, EPS, and guidance vs forecasts
– Volatility spike: Price swings can increase before and after the release

How to use it:
– Track upcoming reports in the Earnings Calendar
– Compare actual results with analyst estimates
– Monitor price reaction and volume on Supercharts
4AB stock is 1.73% volatile and has beta coefficient of 0.01.

What it means:
– Volatility: Shows how much the price fluctuates over time
– Beta > 1: More volatile than the market
– Beta < 1: Less volatile, more stable

Important to know:
– Volatility can increase during earnings, news events, or market stress
– Large-cap stocks like 4AB are typically less volatile than smaller companies

Track every detail on AbbVie, Inc. stock chart and check out the list of the most volatile stocks — is AbbVie, Inc. there?
To understand the 4AB stock performance, it's worth checking price changes for various periods to get the full picture:
– 1 day — −1.70%
– 1 week — +2.62%
– 1 month — +6.22%

4AB all-time low was 24.9 EUR (Jan 14, 2013), and its highest price is 272.3 EUR (Oct 30, 2026). Find more dynamics in the Stock Heatmap and on the AbbVie, Inc. stock chart.
AbbVie, Inc. market capitalization is ‪473.53 B‬, representing the total value of all its outstanding shares (price × shares outstanding).

What it means:
– Market cap is one of the key ways to classify companies (large-cap, mid-cap, etc.)
– It reflects how investors value the company today
– It changes constantly with stock price movements

What to look at next:
– Market cap trends: Rising cap may signal growth and investor confidence; falling cap can reflect risk or downturns
– Price vs shares: Changes can come from AbbVie, Inc. stock price moves or share count (buybacks, issuance)
– Valuation ratios: Compare market cap with revenue and earnings
– Peer comparison: See how AbbVie, Inc. stacks up against other companies
The safest way to buy AbbVie, Inc. stocks is through a reliable broker. Create an account, fund it, and place a buy order.

You can trade 4AB directly from TradingView:
– Choose a broker: Explore our supported trading partners and pick one that fits your needs
– Compare options: View available brokers side by side to evaluate fees and features
– Connect your account: Open Supercharts, click “Trade”, select your broker, and log in
– Start trading: Place orders without leaving the chart

Tip: If you’re new to trading, try paper trading first — it lets you practice strategies in real market conditions without risking funds.
As of Nov 17, 2026, the company has ‪57 K‬ employees.

Why traders follow this data:
– Company scale: Employee count reflects the size and global reach of the business
– Operational footprint: Higher headcount often indicates broader product lines, retail presence, or services
– Trend signal: Changes over time can reflect hiring growth, restructuring, or efficiency improvements

See our rating of the largest employers to find more opportunities.
AbbVie, Inc. pays dividends, but whether it is a “good” dividend stock depends on its yield and stability rather than dividends alone.

Its recent dividend yield was around 2.91%, with a payout ratio of 281.66%, compared to 3.54% and 263.15% in the previous period.

What to look at when looking for good dividend stocks:
– Dividend yield: Income potential relative to price
– Payout ratio: Sustainability of dividend payments
– Dividend history: Consistency and growth over time
– Earnings strength: Dividends are more reliable when supported by stable profits
– Total return: Combines dividends with stock price performance

Explore all this in AbbVie, Inc. financials.
Investing in AbbVie, Inc. depends on your goals, risk tolerance, and market conditions. It’s essential to analyze the stock before making a decision.

First, study AbbVie, Inc. financials and track their dynamics on the Fundamental Graphs:
– Business fundamentals: Revenue, earnings, and growth trends
– Valuation: P/E ratio, market cap, and how it compares to peers
– Profitability: Margins, return on equity, and cash flow
– Dividends (if any): Yield, payout ratio, and consistency

Then explore our 4AB technicals – signals based on essential indicators calculations:
– Today — buy
– 1-week — buy
– 1-month — strong buy

Combine fundamental and technical analysis for better results.
AbbVie, Inc. stock ticker depends on the exchange where it’s listed. On the NYSE, its primary exchange, AbbVie, Inc. stocks trade under the symbol ABBV.

About tickers:
– Unique identifiers: A ticker is a short code used to find and trade a stock
– Exchange-specific: The same company may have different tickers across exchanges
– Search shortcut: Used on trading platforms, charts, and screeners

Remember:
– Some companies have multiple listings
– Always check the exchange prefix to avoid confusion

Learn how to find your desired assets in our Symbol Search.
4AB earnings for the last quarter are 3.37 EUR per share, whereas the estimation was 3.29 EUR, resulting in a 2.51% surprise. The estimated earnings for the next quarter are 3.54 EUR per share.

How to read financials:
– Compare actual vs estimates: Earnings beats or misses often drive price moves
– Watch market reaction: Price response matters as much as the numbers
– Look at forward guidance: Future estimates signal expected growth
– Track trends: Analyze results across multiple quarters, not just one

Follow other essential metrics in AbbVie, Inc. financials:
– Revenue growth: Shows business expansion
– Margins (operating, net): Reflect profitability and efficiency
– Free cash flow: Indicates real cash generation
– Debt levels: Impacts financial stability and risk
AbbVie, Inc. revenue for the last quarter amounts to ‪15.36 B‬ EUR despite the estimated figure of ‪15.29 B‬ EUR. In the next quarter revenue is expected to reach ‪16.68 B‬ EUR.

How to read this data:
– Compare actual vs estimates: Revenue beats or misses can move the stock
– Watch market reaction: Price response shows how investors interpret results
– Look at growth: Compare with previous quarters and year-over-year data
– Track trends: One quarter matters less than consistent performance

Follow other essential metrics in AbbVie, Inc. financials:
– Earnings (EPS): Profitability per share
– Margins (gross, operating): Efficiency and cost control
– Free cash flow: Cash available after expenses
Yes, you can track AbbVie, Inc. financials in yearly and quarterly reports right on TradingView.

Use our Earnings Calendar to never miss important releases and spot opportunities early.
4AB net income for the last quarter is ‪3.71 B‬ EUR, while the quarter before that showed ‪3.15 B‬ EUR of net income which accounts for 17.72% change.

How to read this data:
– Track changes: Compare net income across quarters to spot trends
– Watch expectations: Compare with estimates to gauge performance
– Check margins: Net income reflects profitability after all expenses
– Look beyond one quarter: Consistency matters more than a single result

Follow other essential metrics in AbbVie, Inc. financials:
– Revenue: Overall business growth
– Earnings per share: Rising EPS over time often points to improving business performance
– Margins (gross, operating): Efficiency and cost control
AbbVie, Inc. does pay dividends, which are distributed quarterly. The most recent dividend per share was 1.54 EUR, with a trailing twelve-month (TTM) dividend yield of 2.35%.

Explore more details on AbbVie, Inc. dividends, look at:
– Dividend history: Check whether payouts are growing, stable, or declining
– Payout ratio: How much of earnings are paid out as dividends
– Total return: Combine price growth + dividends for full performance view
4AB reached its all-time high of 272.3 EUR on Oct 30, 2026. Its all-time low was 24.9 EUR and was reached on Jan 14, 2013.

Explore the AbbVie, Inc. stock price chart to see more price history, and discover companies reaching new all-time highs and lows.
AbbVie, Inc. EBITDA is ‪27.89 B‬ EUR, with an EBITDA margin of 47.50%.

EBITDA is a measure of core operating performance, showing how much profit the company generates from its main business activities before accounting for financing and accounting-related costs.

What it means:
– Operating strength: Helps assess profitability from core operations
– Efficiency signal: Rising EBITDA often reflects improving business performance
– Comparability: Useful for comparing companies with different capital structures

What to look at next in AbbVie, Inc. statements:
– Revenue growth: Shows whether the business is expanding
– Net income: Captures full profitability after all expenses
– Free cash flow: Shows actual cash generated
– Debt levels: Important when evaluating earnings quality
Analyst forecasts suggest a price range between 235.92 EUR and 317.59 EUR for 4AB, based on current estimates.

Remember:
– Forecasts show possible scenarios, not guaranteed outcomes
– They're based on multiple analysts’ models and assumptions
– Target prices change with earnings, news, and market conditions

Don't rely on analysts' opinions alone:
– Use technical analysis: Trend, support/resistance, momentum
– Study fundamentals: Revenue, earnings, margins
– Account for market context: News, macro trends, sector performance